How many studies have been conducted on Programmed Cell Death 1 Receptor?

BiohacksAI has indexed 300 PubMed studies on Programmed Cell Death 1 Receptor, including 6 randomized controlled trials (RCTs). 76% of studies involve human subjects.

What are the main research areas for Programmed Cell Death 1 Receptor?

The primary research domains for Programmed Cell Death 1 Receptor are 🔬 Oncology, 🛡️ Immunity, ✨ Skin & Hair. This is based on analysis of 300 PubMed studies using the BiohacksAI evidence platform.

BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.

Programmed Cell Death 1 Receptor

An inhibitory T-lymphocyte receptor that has specificity for CD274 ANTIGEN and PROGRAMMED CELL DEATH 1 LIGAND 2 PROTEIN. Signaling by the receptor limits T cell proliferation and INTERFERON GAMMA synthesis. The receptor also may play an essential role in the regulatory pathway that induces PERIPHERAL TOLERANCE.

300+ PubMed studies analyzed · 6 RCTs · Evidence Score: 51.5

Research Domains

Programmed Cell Death 1 Receptor has been studied across 11 research domains including 🔬 Oncology, 🛡️ Immunity, ✨ Skin & Hair, ⏳ Longevity & Aging, 🫘 Kidney. The primary research focus is 🔬 Oncology with 80% of studies addressing this area.

Loading evidence profile...

This evidence profile for Programmed Cell Death 1 Receptor is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.